- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05491551
Alcohol-ROC-Training (A-ROC-T)
Brief Training for Heavy Drinking Young Adults: Regulation of Alcohol Craving
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hedy Kober, PhD
- Phone Number: 917-470-8331
- Email: hedy.kober@yale.edu
Study Contact Backup
- Name: Corey Roos
- Phone Number: 203-623-5882
- Email: corey.roos@yale.edu
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Recruiting
- Yale University
-
Contact:
- Hedy Kober, PhD
- Phone Number: 917-470-8331
- Email: hedy.kober@yale.edu
-
Contact:
- Corey Roos, PhD
- Phone Number: 2036235882
- Email: corey.roos@yale.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
(1) Young adults ages 18-26 years, who (2) report ≥ 3 heavy drinking days (i.e., heavy drinking defined by >3 drinks for women, >4 drinks for men) in the prior month; (3) are motivated to quit or reduce drinking; (4) are fluent in English and have a 6th grade or higher reading level; (5) have access to a computer with working internet; (6) use a working smartphone; (7) can commit to the full length of the protocol; and (8) are willing to be randomized to intervention condition.
Exclusion Criteria:
(1) Current (past 12 months) clinically-severe alcohol use disorder (AUD; e.g., history of seizures, delirium, or hallucinations during withdrawal) or current severe alcohol withdrawal; (2) Current (past 12 months) clinically-severe substance use disorder (except tobacco) or current severe drug withdrawal; (3) serious other psychiatric illness by history or examination; (4) severe or unstable physical disease within the past 6 months; (5) psychoactive medications (e.g., mood stabilizers) that have not been at a stable dose unless determined to be on a stable dose of medication by the study psychiatrist; (6) current use of any investigational medication; (7) color blindness; (8) biological females who are pregnant; and (9) notable dislike to any particular type of alcoholic beverage depicted in study stimuli; (10) Participants who will not complete at least 70% of past day EMA reports in the pre-intervention phase will not be randomized; (11) Participants who cannot understand or follow study-related instructions (e.g., unable to correctly use the intervention strategies, indicate lack of understanding of study instructions despite multiple attempts).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness-Based Treatment
Using mindfulness and meditative strategies to control craving
|
Participants will be trained in using the MBT-based mindfulness strategy as described above ("notice craving and accept the feeling without judgment or reaction").
Participants will then be instructed to think of accepting and non-reactive responses when they see the instruction "ACCEPT" during ROC-T.
On each trial, participants will receive an instruction and then be exposed to a novel alcohol image for 6 seconds.
On 25% of the trials, they will see the LOOK instruction, and be allowed to experience craving (as baseline).
On 75% of the trials, participants will see ACCEPT and then practice thinking about the negative consequences of drinking.
After the picture disappears, they will rate their craving on every trial using a 1-5 Likert scale.
Other Names:
|
Experimental: Cognitive Behavioral Therapy
Thinking of negative consequences to control craving
|
Participants will be trained in using the CBT strategy by first considering and reading about the negative consequences of drinking.
Participants will then be instructed to think of those negative consequences ("Focus on the negative consequences associated with drinking)" when they see the instruction "REFRAME" during ROC-T.On each trial, participants will receive an instruction and then be exposed to a novel alcohol image for 6 seconds.
On 25% of the trials, they will see the LOOK instruction, and be allowed to experience craving (as baseline).
On 75% of the trials, participants will see REFRAME and then practice thinking about the negative consequences of drinking.
After the picture disappears, they will rate their craving on every trial using a 1-5 Likert scale
Other Names:
|
No Intervention: Control
No regulatory strategy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in frequency of heavy drinking days
Time Frame: From baseline to 2-weeks post-intervention and to the 10-week follow-up
|
Self-reports of daily alcohol use via smartphone-based ecological momentary assessment (EMA) is the primary source for this outcome variable, with Timeline Follow-Back (TLFB) data inserted to replace missing data from EMA.
A heavy drinking day is defined as more than 3 or 4 standard drinks per day for women/men.
|
From baseline to 2-weeks post-intervention and to the 10-week follow-up
|
Change in average estimated blood alcohol concentration (eBAC) per drinking day
Time Frame: From baseline to 2-weeks post-intervention and to the 10-week follow-up
|
Daily self-reports of alcohol use via smartphone-based ecological momentary assessment (EMA) is the primary source for this outcome variable, with Timeline Follow-Back (TLFB) data inserted to replace missing data from EMA.
Estimated blood alcohol concentration (eBAC) is based on number of standard drinks reported per day, duration of drinking, and total body water (based on sex, age, height, and weight).
|
From baseline to 2-weeks post-intervention and to the 10-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in alcohol-related negative consequences
Time Frame: From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Daily self-reports of alcohol-related negative consequences (Brief Young Adult Alcohol Consequences Questionnaire) via smartphone-based ecological momentary assessment (EMA) is the primary source for this outcome variable.
Total scores range from 0 to 24, with higher scores indicating greater alcohol-related negative consequences.
|
From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Reduction in World Health Organization (WHO) drinking risk level
Time Frame: From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Drinking risk levels are based on grams of pure alcohol per day in a given period and include abstinent (0 grams males/females), low risk (1 to 40g males/1 to 20g females), medium risk (41 to 60g males/21 to 40g females), high risk (61 to 100g males/41 to 60g females), or very high risk (greater to or equal to 101g males/61g females).
|
From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in momentary alcohol craving in daily life
Time Frame: From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Twice daily self-reports of momentary craving for alcohol via smartphone-based ecological momentary assessment (EMA).
Alcohol craving scores range from 0 to 10, with higher scores indicating greater alcohol craving.
|
From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Change in momentary acceptance of craving in daily life
Time Frame: From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Twice daily self-reports of momentary acceptance of alcohol craving via smartphone-based ecological momentary assessment (EMA).
Acceptance of alcohol craving scores range from 0 to 10, with higher scores indicating greater acceptance of alcohol craving.
|
From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Change in momentary reframing of craving in daily life
Time Frame: From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Twice daily self-reports of momentary reframing of alcohol craving via smartphone-based ecological momentary assessment (EMA).
Reframing of alcohol craving scores range from 0 to 10, with higher scores indicating greater reframing of alcohol craving.
|
From baseline to 2-weeks post-intervention and the 10-week follow-up
|
Change in momentary craving during Regulation of Craving (ROC) task
Time Frame: From baseline ROC task to post-intervention ROC task (approximately 3 weeks)
|
The ROC task involves viewing a series of alcohol images and following various instructions on particular trial when an alcohol image is shown.
Participants report self-reported craving after each trial.
There are 3 types of trials: 1) LOOK = look at alcohol image, 2) ACCEPT = use acceptance strategy, and 3) REFRAME = use the reframing strategy.
|
From baseline ROC task to post-intervention ROC task (approximately 3 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hedy Kober, Ph.D., Yale University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000029394
- 1R01AA029137-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
We will adhere to the NIH Grants Policy on Sharing of Unique Research Resources.
In compliance with HIPAA and Yale Human Investigation Committee standards, any data sets that will be shared will not include any personally identifiable information. Requests for data sharing will be considered within the context of ongoing and planned research being performed within the research group at Yale in order to avoid duplication of effort and overlap in data analysis that might compromise communication of findings. Data to be shared will be de-identified and transmission electronically and securely, as we have done previously with investigators at other institutions.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Binge Drinking
-
HBSARecruitingBinge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related HarmsUnited States
-
Mayo ClinicJames and Esther King Biomedical Research ProgramCompletedfor Cigarette Smoking and Binge Drinking CessationUnited States
-
University of North Carolina, Chapel HillAgency for Healthcare Research and Quality (AHRQ)CompletedAlcohol Use Disorder | Drinking, Alcohol | Drinking Excessive | Risky Health Behavior | Drinking, BingeUnited States
-
University of Southern CaliforniaNot yet recruitingBinge Drinking | Binge Eating
-
Pacific Institute for Research and EvaluationKlein Buendel, Inc.CompletedAggression | Drug Use | Peer Group | Drink Too Much | Drink Driving | Drinking, Binge | Drunk | Aggression SexualUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedTobacco Use Cessation | Adherence | Alcohol & Drug Use | Nicotine Transdermal SystemUnited States
-
Centre Hospitalier Universitaire, AmiensEPSM Marne, Reims; SCA-LAB UMR-CNRS 9193, Lille; Paul Valery University, MontpellierRecruitingAlcohol Drinking | Binge DrinkingFrance
-
University of MinhoFoundation for Science and Technology (FCT)Recruiting
-
University Hospital, CaenRecruitingAlcohol Drinking | Binge DrinkingFrance
-
University of MinhoCompletedBinge DrinkingPortugal
Clinical Trials on Mindfulness-Based Treatment-Regulation of Craving
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
University Hospital TuebingenUnknownDepressive Disorder | Depression | RuminationGermany
-
University of OregonOhio State UniversityRecruitingSmoking Cessation | Cancer | Smoking ReductionUnited States
-
Hospital Universitario La PazRecruiting
-
National Taiwan University HospitalUnknownStress, Psychological | Unipolar Depression | Psychophysiologic DisordersTaiwan
-
Lund UniversityCompleted
-
West Virginia UniversityRecruitingSmoking Reduction | Smoking BehaviorsUnited States
-
Yale UniversityTerminatedAlcohol Drinking | Drinking Behavior | Binge Drinking | Heavy Drinking | College Drinking | Alcohol Drinking in College | Young Adult | Heavy Drinker | Drunkenness | Drinking Excessive | Drinking Problem | Drink Too MuchUnited States
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingObesity, ChildhoodUnited States
-
Ruhr University of BochumUniversity of British Columbia; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedHypoactive Sexual Desire DisorderGermany